Entity type
Individual
Filer Snapshot
Lance Alstodt
CIK 0001756228. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
3
Latest filing
19 Feb 2025
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: 13D/G stake for BRTX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
BRTX
14 Feb 2025 · 16% ownership
Open 13D/GInsider / owner context
BRTX
06 Oct 2025 · $300K
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Schedule 13D/G
View source filing
SCHEDULE 13D/A filed on 19 Feb 2025 for CIK 0001756228.
- Parsed SEC ownership signals
-
Parsed SEC ownership coverage
These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.
Forms 3/4/5 positions$300KReporting-owner positions with enough filing detail to estimate value.
Forms 3/4/5 position value
3/4/5$300KEstimated from parsed Forms 3/4/5 when filings include enough share and price data.
Largest linked holdings
Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.
BRTXLargest active 13D stakes
Active large-stake positions disclosed in parsed Schedule 13D filings.
BRTXHow to read these SEC ownership signals
- Read each filing family separately: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different SEC disclosure questions.
- Open the linked research path when you need the filing, CIK, issuer, or CUSIP trail behind a value.
- Business address
- Biorestorative Therapies, Inc., 40 Marcus Drive, Suite 1, Melville, NY, 11747
Ownership signals
CIK-linked ownership evidence from parsed SEC filings.
1 signal
At a glance
Names, identifiers, and filing context for this profile.
1 identity field
Filer intelligence
What SEC filings say about Lance Alstodt
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- 1 recent 13D/G stake row found; top row is BRTX at 16% ownership.
- Forms 3/4/5 show insider context for BRTX worth $300K.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13D/G large-stake context
BRTX
14 Feb 2025 · Common Stock
Forms 3/4/5 insider context
BRTX
06 Oct 2025 · President, CEO, COB · 10% owner
Latest update
What changed recently for Lance Alstodt
Latest ownership report period: 06 Oct 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
20 Oct 2025
Page type
Ownership filings
Latest period
06 Oct 2025
Ownership context was refreshed from SEC Forms 3/4/5 filed on 20 Oct 2025.
SEC filing record
CIK 0001756228 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
3
First seen
06 Sep 2023
Latest filing
19 Feb 2025
Entity
Individual
Observed form types
4
SCHEDULE 13D/A
CIK-linked evidence first
Latest Filings
Showing the latest 3 of 3 SEC filings for Lance Alstodt.
SCHEDULE 13D/A
SCHEDULE 13D/A filing
- Filing date
- 19 Feb 2025
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 13 Sep 2023
- Reporting date
- 13 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 06 Sep 2023
- Reporting date
- 06 Sep 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing